| Wissenschaftl. Titel | A Phase 1/1b, Open-label, Multicenter, Dose Escalation and Dose Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of KQB198 as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hematologic Malignancies |
| Erkrankung | |
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 07.11.2024 Admin04
geändert 18.11.2024 Admin02